Rashid Abdulaziz Al Duaij
⚠️ High Risk
FEI: 3005187156 • Dhahran • SAUDI ARABIA
FEI Number
3005187156
Location
Dhahran
Country
SAUDI ARABIAAddress
Po Box 431, , Dhahran, , Saudi Arabia
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 8/15/2005 | 60LCA05ASPIRIN (ANALGESIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 60LCA05ASPIRIN (ANALGESIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 60LCA99ANALGESIC, N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 66SCA28NITROGLYCERIN (TAB) (VASODILATOR) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 62KCA10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 61JCA14SIMVASTATIN (ANTI-CHOLESTEREMIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 60XCA17ATENOLOL (ANTI-ADRENERGIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 62OCA41LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 60LCA05ASPIRIN (ANALGESIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 61PCA31GLIMEPIRIDE (ANTI-DIABETIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 62OCA14AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 8/15/2005 | 64BCA25HYDROCHLOROTHIAZIDE (DIURETIC) | 75UNAPPROVED | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Rashid Abdulaziz Al Duaij's FDA import refusal history?
Rashid Abdulaziz Al Duaij (FEI: 3005187156) has 12 FDA import refusal record(s) in our database, spanning from 8/15/2005 to 8/15/2005.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Rashid Abdulaziz Al Duaij's FEI number is 3005187156.
What types of violations has Rashid Abdulaziz Al Duaij received?
Rashid Abdulaziz Al Duaij has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Rashid Abdulaziz Al Duaij come from?
All FDA import refusal data for Rashid Abdulaziz Al Duaij is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.